RHBC
BMY icon

R.H. Bluestein & Co’s Bristol-Myers Squibb BMY Stock Holding History

R.H. Bluestein & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,620
Closed -$283K – 321
2017
Q4 		$283K Sell
4,620
-2,710
-37% -$170K 0.01% 254
2017
Q3 		$467K Buy
+7,330
New +$428K 0.03% 168
2017
Q1 		– Sell
-413,877
Closed -$24.2M – 325
2016
Q4 		$24.2M Sell
413,877
-161,486
-28% -$8.83M 1.58% 32
2016
Q3 		$31M Sell
575,363
-325
-0.1% -$20.9K 2.04% 27
2016
Q2 		$42.3M Buy
575,688
+57,785
+11% +$4.08M 3.24% 9
2016
Q1 		$33.1M Sell
517,903
-50,597
-9% -$3.19M 2.39% 14
2015
Q4 		$39.1M Buy
568,500
+44,993
+9% +$2.97M 2.44% 14
2015
Q3 		$31M Sell
523,507
-27,093
-5% -$1.72M 2.2% 19
2015
Q2 		$36.6M Buy
550,600
+203,803
+59% +$13.4M 2.22% 17
2015
Q1 		$22.4M Buy
346,797
+18,033
+5% +$1.13M 1.35% 36
2014
Q4 		$19.4M Sell
328,764
-6,549
-2% -$369K 1.21% 36
2014
Q3 		$17.2M Sell
335,313
-3,818
-1% -$191K 1.08% 40
2014
Q2 		$16.5M Sell
339,131
-67,170
-17% -$3.31M 0.98% 43
2014
Q1 		$21.1M Sell
406,301
-11,164
-3% -$594K 1.39% 30
2013
Q4 		$22.2M Sell
417,465
-64,945
-13% -$3.31M 1.4% 27
2013
Q3 		$22.3M Sell
482,410
-120,456
-20% -$5.29M 1.58% 28
2013
Q2 		$26.9M Buy
+602,866
New +$26.2M 2.37% 12

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

R.H. Bluestein & Co's BMY Position: Q1 2018 in Review

R.H. Bluestein & Co sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 4,620 shares — an estimated $283K sold.

R.H. Bluestein & Co first reported a position in BMY in Q2 2013 and held it in 17 quarters. The position peaked at $42.3M in Q2 2016. 1,746 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

  • R.H. Bluestein & Co reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
  • R.H. Bluestein & Co sold 4,620 Bristol-Myers Squibb shares in Q1 2018, an estimated $283K.
  • R.H. Bluestein & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 17 quarters.
  • R.H. Bluestein & Co's Bristol-Myers Squibb position peaked at $42.3M in Q2 2016.
  • 1,746 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on R.H. Bluestein & Co's 13F filing for Q1 2018, filed 10 May 2018.